Cryosa(CYRX)

Focus: Cryosa is a public biotechnology company specializing in cryotherapy-based procedures for obstructive sleep apnea treatment, operating at a mid-cap scale with $169M in FY2025 revenue.

Unknown Obstructive Sleep Apnea

Profile data last refreshed 18h ago · AI intelligence enriched 2w ago

Funding Stage

PUBLIC

Employees

1,100

Open Jobs

About Cryosa

AI assessmentNot Hiring

No open roles listed right now. Follow Cryosa to get notified when they start hiring — the background below is worth knowing for when they do.

Why Work Here

Data completeness

3/9 — Basic

Company HealthSolid

Pipeline

Early-stage

4 total

LOE Risk

Protected

No near-term cliffs

Hiring

0 open

Revenue

$169M

Key Products

Cryosa Procedure

Obstructive Sleep Apnea (Adult)

Growth

Core proprietary procedure representing primary commercial asset, but specific revenue contribution undisclosed.

CHILLS Procedure

Obstructive Sleep Apnea (Adult)

Growth

Help build intelligence for Cryosa

No one has shared interview or compensation data for this company yet. You'll earn 7 days of Pro access.

Share Interview Share Compensation

Data Sources

Drug label: DailyMed / FDA
Clinical trials: ClinicalTrials.gov
Patent data: FDA Orange Book
Spending data: CMS Medicare

The information on this page is for informational purposes only and should not be used as a substitute for professional medical advice. Drug information is sourced from FDA, DailyMed, and other government databases. Adverse event data from FAERS does not establish causation. Always consult a healthcare professional for medical decisions.

Public company status (CYRX) provides equity liquidity and career visibility in a defined market segment
Established 18-year history with $169M revenue base indicates operational maturity and relative stability
Focused therapeutic area (sleep breathing) allows deep domain expertise development without competing across broad indications

Watch Out For

Revenue declined 29% YoY ($237M→$169M) while losses doubled to -$99.6M in FY2025, signaling serious commercialization or market challenges
Cash position compressed 37% to $29M, raising near-term solvency concerns and limiting hiring/investment capacity
Only 2 active job openings and flat hiring (2 Engineering roles only) suggest organizational contraction or hiring freeze

Generated by Claude from Cryosa's SEC filings, pipeline programs, hiring velocity, FDA actions, and WARN data. Inference, not editorial — verify before quoting.

Automated analysis based on publicly available data (FDA, SEC, ClinicalTrials.gov). May be incomplete or delayed. This score does not reflect insider knowledge and should not be used as the sole basis for investment or employment decisions.

Secondary procedure candidate in same indication; unclear differentiation or commercial status relative to Cryosa Procedure.

Pipeline & Clinical Trials

Cryosa Procedure

Obstructive Sleep Apnea of Adult

N/A

Clinical Trials (1)

NCT06008626Clinical Trial of the Cryosa System for the Treatment of Obstructive Sleep Apnea

N/A

CHILLS Procedure

Obstructive Sleep Apnea of Adult

N/A

Clinical Trials (1)

NCT05542082Pilot Study of the CHILLS Cryotherapy System for the Treatment of OSA

N/A

Cryosa Procedure

Obstructive Sleep Apnea (OSA)

N/A

Clinical Trials (1)

NCT07021833Clinical Trial of the Cryosa System for the Treatment of Obstructive Sleep Apnea (ARCTIC_AUS)

N/A

CHILLS Procedure

Obstructive Sleep Apnea of Adult

N/A

Clinical Trials (1)

NCT04864652Safety and Dosing Study of the CHILLS Cryotherapy for the Treatment of OSA

N/A

Open Jobs (0)

No open positions listed yet. Check their careers page directly.

Interview Prep Quick Facts

Founded: 2006

Portfolio: 4 clinical trials

Publications: 3 in PubMed

SEC Filings: 2 available

Financials (FY2025)

Revenue

$169M29%

R&D Spend

$18M(11%)15%

Net Income

-$100M

Research Publications(3)

Recent peer-reviewed publications with author affiliations at this company

Selective Adipose Cryolysis for Reduction of Lingual Tissue in a Porcine Model.

Otolaryngology--head and neck surgery : official journal of American Academy of Otolaryngology-Head and Neck Surgery

2025

PMID:39692255

Morphometric and Immunohistochemical Characteristics of the Adult Human Soft Palate Muscles.

The journal of histochemistry and cytochemistry : official journal of the Histochemistry Society

2022

PMID:34957888

Pro Feature

Upgrade to Pro to access AI interview prep brief and other premium pharma intelligence.

Upgrade to Pro — $25/mo